Optical Hemoglobin Variant Detection via Spectral Shift Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting hemoglobin variants, such as sickle cell disease, rely on invasive procedures and cannot accurately characterize in vivo hemoglobin oxygen affinity due to varying environmental conditions, making rapid and reliable screening challenging.
Innovation Solution
The method utilizes optical absorption spectroscopy to differentiate between oxygenated and deoxygenated hemoglobin by measuring bathochromic and hypochromic shifts in absorption spectra, allowing for the detection and quantification of hemoglobin variants based on unique spectral shifts, which are correlated with oxygen affinity and concentration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If optical absorption spectroscopy is used to detect hemoglobin variants, then screening speed and non-invasiveness are improved, but measurement precision under varying environmental conditions deteriorates
Solution Approach 1:
The patent applies parameter changes by measuring absorption spectra at multiple different pH values (at least two distinct pH levels) to capture the Bohr effect variations. This allows the system to distinguish between true oxygen affinity changes and pH-induced spectral shifts, thereby maintaining measurement precision while enabling rapid non-invasive screening through optical spectroscopy.
Solution Approach 2:
The system uses feedback by comparing measured absorption spectra against reference spectra obtained under controlled conditions. The device incorporates algorithms that analyze spectral differences and compensate for environmental variations, providing corrected oxygen affinity measurements that maintain precision despite varying in vivo conditions.
2Reliability
If standardized environmental conditions are used for in vitro oxygen dissociation curve measurement, then measurement consistency is improved, but in vivo relevance deteriorates
Solution Approach 1:
The patent measures absorption spectra at multiple pH values including physiological pH (7.40) and altered pH conditions. By capturing spectral data across a range of pH values, the system maintains consistency through standardized measurement protocols while simultaneously representing in vivo conditions where pH varies between 7.35-7.45 and can shift during disease states or exercise.
Solution Approach 2:
The device serves multiple functions by既能 measuring oxygen affinity under standardized conditions for consistency,又能 assessing oxygen affinity under physiologically relevant pH variations. This multi-functionality allows a single device to provide both research-grade consistent data and clinically relevant in vivo predictions.
3Measurement precision
If multiple pH levels are measured to account for the Bohr effect, then oxygen affinity assessment accuracy is improved, but device complexity and measurement time increase
Solution Approach 1:
The patent implements a practical solution by measuring at at least two distinct pH values (including physiological pH 7.40 and one other pH level). This balanced approach improves oxygen affinity assessment accuracy by capturing Bohr effect variations while avoiding excessive complexity that would result from measuring at every possible pH level.
Solution Approach 2:
The system applies partial action by selecting specific critical pH values for measurement rather than continuous pH scanning. This provides sufficient accuracy for clinical decision-making without the excessive complexity of comprehensive pH profiling, achieving an optimal balance between precision and practicality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables rapid, non-invasive detection of hemoglobin variants and assessment of oxygen affinity, providing clinical insights into sickle cell disease and potential therapeutic effects, with high correlation between spectral shifts and HbS concentration and oxygen affinity.
Implementation Method 1
The method utilizes optical absorption spectroscopy to differentiate between oxygenated and deoxygenated hemoglobin by measuring bathochromic and hypochromic shifts in absorption spectra
Implementation Method 2
the absorption spectra of HbS exhibit right peak wavelength shift (bathochromic shift) and reduction in optical density (hypochromic shifts) that differ from normal hemoglobin (HbA)
Data Source
AI summary
A method of determining at least one of hemoglobin oxygen affinity, rate of hemoglobin deoxygenation, or the presence of hemoglobin variants in blood of a subject, the method includes determining differences of absorption spectra of oxygenated and deoxygenated hemoglobin, red blood, and/or blood obtained from the subject and comparing the determined absorption spectra differences to a control value, wherein the absorption spectra differences are indicative of hemoglobin oxygen affinity, rate of hemoglobin deoxygenation, or the presence of hemoglobin variants in the blood of the subject.